1. Home
  2. SRPT vs IT Comparison

SRPT vs IT Comparison

Compare SRPT & IT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRPT
  • IT
  • Stock Information
  • Founded
  • SRPT 1980
  • IT 1979
  • Country
  • SRPT United States
  • IT United States
  • Employees
  • SRPT N/A
  • IT N/A
  • Industry
  • SRPT Biotechnology: Pharmaceutical Preparations
  • IT Other Consumer Services
  • Sector
  • SRPT Health Care
  • IT Consumer Discretionary
  • Exchange
  • SRPT Nasdaq
  • IT Nasdaq
  • Market Cap
  • SRPT N/A
  • IT N/A
  • IPO Year
  • SRPT 1997
  • IT 1993
  • Fundamental
  • Price
  • SRPT $37.60
  • IT $436.42
  • Analyst Decision
  • SRPT Buy
  • IT Buy
  • Analyst Count
  • SRPT 23
  • IT 8
  • Target Price
  • SRPT $125.43
  • IT $517.13
  • AVG Volume (30 Days)
  • SRPT 5.9M
  • IT 586.4K
  • Earning Date
  • SRPT 05-06-2025
  • IT 05-06-2025
  • Dividend Yield
  • SRPT N/A
  • IT N/A
  • EPS Growth
  • SRPT N/A
  • IT 59.64
  • EPS
  • SRPT N/A
  • IT 16.06
  • Revenue
  • SRPT $2,233,371,000.00
  • IT $6,328,615,000.00
  • Revenue This Year
  • SRPT $39.01
  • IT $7.86
  • Revenue Next Year
  • SRPT $13.35
  • IT $6.79
  • P/E Ratio
  • SRPT N/A
  • IT $27.17
  • Revenue Growth
  • SRPT 59.15
  • IT 5.99
  • 52 Week Low
  • SRPT $34.10
  • IT $366.05
  • 52 Week High
  • SRPT $173.25
  • IT $584.01
  • Technical
  • Relative Strength Index (RSI)
  • SRPT 33.31
  • IT 50.78
  • Support Level
  • SRPT $36.89
  • IT $436.86
  • Resistance Level
  • SRPT $39.56
  • IT $446.32
  • Average True Range (ATR)
  • SRPT 2.14
  • IT 6.29
  • MACD
  • SRPT 0.95
  • IT -1.45
  • Stochastic Oscillator
  • SRPT 34.86
  • IT 29.41

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

Share on Social Networks: